Dr. ankur gupta Sr. medical advisor Msd india

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

Context  Best Care Always! (BCA), is an initiative aimed at improving patient safety and spreading improvement methods in all South African hospitals.
Drug Utilization Review (DUR)
1 1 Slide © 2008 Thomson South-Western. All Rights Reserved Chapter 17 Index Numbers n Price Relatives n Aggregate Price Indexes n Computing an Aggregate.
Steady persistence while chasing the elusive: When guidelines and policies for antimicrobial use clash with the 800 pound gorilla Gerald Yonga*, Sital.
Part II – TIME SERIES ANALYSIS C2 Simple Time Series Methods & Moving Averages © Angel A. Juan & Carles Serrat - UPC 2007/2008.
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
1 Drug and Therapeutics Committee. Objectives  Discuss the use of aggregate data including defined daily dose in analyzing the consumption of medicines.
Ministry of Health People’s Republic of ChinaPage 1 中华人民共和国 卫生部 Promoting Rational Antibiotic Prophylaxis in Clean Surgeries in China, Zheng, Yingdong;
Health Programme Evaluation by Propensity Score Matching: Accounting for Treatment Intensity and Health Externalities with an Application to Brazil (HEDG.
Introduction There are few public health issues of greater importance than antimicrobial resistance in terms of impact on society. This problem is not.
Antimicrobial Stewardship
1 1 Slide Slides Prepared by JOHN S. LOUCKS St. Edward’s University © 2002 South-Western/Thomson Learning 
1 Anti-psychotic Medication in Children, Adolescents and Foster Care: Too Many, too Much, and too Young Medicaid Medical Directors Learning Network (MMDLN)
IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
Update on Antibiotic Usage in the Pig Sector Caroline Garvan, Veterinary Inspector.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
1 Antibiotic Resistance: An Update Janice Soreth, M.D. Director Division of Anti-Infective Drug Products February 20, 2002.
Chapter Legislative Representatives Government Affairs Update April 2014.
Improving Nursing Home Compare for Consumers Five-Star Quality Rating System.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar.
Surgical antibiotic prophylaxis at Moi Teaching & Referral Hospital Rose Kakai 1, Barrack Ayumba 2, Damaris Lagat 2, Eveline Wesangula 3, Sam Kariuki 4.
The utilisation of drugs (medicines) is reflected and described in the
Antimicrobial Stewardship
Background and purpose
NHS RightCare scenario: Getting the dementia pathway right
Antibiotics: handle with care!
Trials Adrian Boyle.
Person Centeredness in Quality Measurement
ANTI-MICROBIAL USAGE IN THE COMMUNITY AND RESISTANCE IN E.COLI
Dr. Daniele Wikoff – ToxStrategies Experimental Biology 2017
Care Act and young people with Sensory Impairments
Weight of Evidence for Regional Haze Reasonable Progress
Emerging and developing economies: measures of development
Pharmacy Executive Forum - Benchmarking
Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose Stephen.
Background Goals Methods Conclusions Results
Does Diet Environment Affect Our Fruit and Vegetable Consumption?
The Financial and Jobs Pictures
Exploring the role of nurses in Antimicrobial Stewardship at Sheffield Teaching Hospitals NHS Foundation Trust Antimicrobial Nurse.
Developing and Marketing Products
Item 21: Purchasing Power Parities
Presenter: Julie Paronish Faculty Advisor: Nancy W. Glynn, PhD
Scotland – Mental Health data and metrics
Antibiograms: “What and Why?”
Hospital Antibiotic Stewardship Programs
Intermountain APIC Chapter CIC training questions
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Presentation Title 36pt Arial Bold
Measuring perceptions of safety climate in primary care
Chapter 14 Developing and Marketing Products
Data Collection Training, Part I Outcome Data
B. Huttner, S. Harbarth, D. Nathwani 
Impact of an essential drugs list and treatment guidelines on prescribing in South Africa.
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Associate Director, Antimicrobial Stewardship
Antibiotic usage and the incidence of resistance
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
ANTIBIOTIC STEWARDSHIP PROGRAM
Chapter 3 INDEX NUMBERS Dr. A. PHILIP AROKIADOSS Assistant Professor
Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France  B. Amadeo, C. Dumartin,
Main recommendations and Impact on Social Statistics
A LONGITUDINAL POLICY ANALYSIS OF THE IMPACT ON PRESCRIBING PATTERNS AND MEDICATION COST OF A GENERIC DISPENSING POLICY IN A TEACHING HOSPITAL IN THAILAND.
Blanchard Valley Health System Antimicrobial Stewardship Program
Discussion and Action Plan
Antimicrobial Stewardship – Northern Ireland Experience
Presentation transcript:

Dr. ankur gupta Sr. medical advisor Msd india Drug Resistance Index Dr. ankur gupta Sr. medical advisor Msd india

Why we need DRI ? Communicating the antimicrobial resistance to policymakers and non-experts is a challenge It is complicated by the multiplicity of bacterial pathogens and distinct classes of antibiotics used to treat them. It is difficult, even for experts to infer the seriousness of resistance whether alternative antibiotics are available. Difficulty in aggregating resistance to multiple drugs to assess trends poses a further challenge to quantifying and communicating changes in resistance over time and across locations.

What is Drug Resistance Index (DRI) DRI is a method for aggregating bacterial resistance to multiple antibiotics, creating an index comparable to the composite economic indices that measure consumer prices and stock market values. The resulting drug resistance index (DRI) and various sub-indices show antibiotic resistance and consumption trends

Raw materials to calculate DRI DRI can be measured at facility level of ward level to measaure the performance of stewardship efforts Two ingredients to calculate DRI are Consumption of antibiotic data from pharmacy Antibiogram from the microbiologists DRI is measured in 3 simple steps Preparing resistance data (antibiogram) Preparing utilisation data (antibiotic consumption) Collating information and calculating DRI

Plotting of DRI curve Values show overall resistance, adjusted for the prescribed volume in each period.

Interpretation of DRI value The DRI produces a number between 0 and 1 It is a relative value expressing the overall susceptibility of that species to the basket of antibiotics available to treat it. It should not be understood as multidrug resistance, but rather the proportion of resistant isolates adjusted for the relative importance (i.e. prescribed volume) of each drug in each period. The strength of any index is that it makes comparisons over both time and location substantially easier. For example, an increase in the DRI of Pseudomonas from 0.56 to 0.6 in the next month tells you that that infection has become more difficult to treat, taking into account any changes in prescribing patterns towards more effective antibiotics. Furthermore, a Pseudomonas DRI of 0.56 in one facility vs. a value of 0.47 in another allows for relative comparisons of resistance between locations.

Tracking DRI over a period of time

DRI – Tool for AMS and Infection control in Hopsital DRI can become an extended arm of Antimicrobial Stewardship (AMS) DRI has the potential to become an effective outcome measure to assess the impact of AMS implementation on change in antimicrobial resistance DRI can change the outlook of hospital owners and healthcare professionals towards antibiotic resistance. DRI can potentially become a marketing tool for hospitals to advertise their infection control and effort on curbing antimicrobial resistance as compared to competitors

DRI – An Update from India Have completed the pilot DRI calculation for 3 Fortis Hospitals MSD India has signed a 3 year exclusive partnership with CDDEP for extension and dissemination of DRI in hospitals across India Have entered into an agreement with Apollo group of hospitals for Pan – Apollo rollout of DRI as an initial step towards AMS implementation

The expected support on DRI To adopt and own AMS and DRI as signature campaigns by Merck / MSD across AP region / emerging markets for countering antimicrobial resistance To create think tank of KOLs across these regions with strong endorsement for DRI as a tool to measure and track antimicrobial resistance To influence the health authorities of repute in the world to validate and include DRI as a surrogate tool to measure and track antimicrobial resistance

Back up slides How to measure DRI

Step 1: Preparing resistance data (antibiogram)

Step 2: Preparing Utilization data (consumption) Use (Consumption) = DDD / BD × 100 DDD (Defined Daily Dose) = Total Antibiotic consumption (gm) / Total Adult Daily Dose (gm) BD (Bed Days) = 365 (for 1 yr) × Total beds in hospital × Occupancy Index

Step 3: Calculating DRI Use weight = Proportion of a drug used over combined usage of all drugs Weighted resistance = Resistance rate × Use weight Index Value = Sum of Weighted resistace